Subramanian Sanjay
Insider CIK 1790246 · SCYX Chief Financial Officer · OCGN Chief Financial Officer · INZY SVP, CFO & Head of BD
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SCYX SCYNEXIS INC | A Award deriv | 2026-09-09 | 2026-09-11 | 100,000 | — | $0 | 100,000 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2026-09-09 | 2026-09-11 | 100,000 | — | $0 | 100,000 | SEC↗ |
| INZY Inozyme Pharma, Inc. | D To issuer deriv | 2025-07-01 | 2025-07-03 | 38,500 | — | $0 | 0 | SEC↗ |
| INZY Inozyme Pharma, Inc. | D To issuer deriv | 2025-07-01 | 2025-07-03 | 180,000 | — | $0 | 0 | SEC↗ |
| INZY Inozyme Pharma, Inc. | D To issuer deriv | 2025-07-01 | 2025-07-03 | 135,000 | — | $0 | 0 | SEC↗ |
| INZY Inozyme Pharma, Inc. | D To issuer deriv | 2025-07-01 | 2025-07-03 | 145,000 | — | $0 | 0 | SEC↗ |
| INZY Inozyme Pharma, Inc. | U Tender | 2025-07-01 | 2025-07-03 | 39,701 | $4.00 | $158.8K | 0 | SEC↗ |
| INZY Inozyme Pharma, Inc. | A Award | 2025-06-25 | 2025-06-27 | 6,813 | $0.74 | $5.0K | 39,701 | SEC↗ |
| INZY Inozyme Pharma, Inc. | A Award | 2025-03-31 | 2025-04-02 | 2,490 | $0.77 | $1.9K | 32,888 | SEC↗ |
| INZY Inozyme Pharma, Inc. | A Award deriv | 2025-03-11 | 2025-03-17 | 38,500 | — | $0 | 38,500 | SEC↗ |
| INZY Inozyme Pharma, Inc. | A Award deriv | 2025-03-11 | 2025-03-17 | 145,000 | — | $0 | 145,000 | SEC↗ |
| INZY Inozyme Pharma, Inc. | A Award deriv | 2024-03-13 | 2024-03-15 | 165,000 | — | $0 | 165,000 | SEC↗ |
| INZY Inozyme Pharma, Inc. | A Award | 2023-09-29 | 2023-10-03 | 2,319 | $3.57 | $8.3K | 30,398 | SEC↗ |
| INZY Inozyme Pharma, Inc. | A Award | 2023-03-31 | 2023-04-04 | 979 | $2.21 | $2.2K | 28,079 | SEC↗ |
| INZY Inozyme Pharma, Inc. | A Award deriv | 2023-03-23 | 2023-03-27 | 135,000 | — | $0 | 135,000 | SEC↗ |
| INZY Inozyme Pharma, Inc. | P Buy | 2022-04-19 | 2022-04-20 | 27,100 | $3.69 | $100.0K | 27,100 | SEC↗ |
| INZY Inozyme Pharma, Inc. | A Award deriv | 2022-03-21 | 2022-03-22 | 180,000 | — | $0 | 180,000 | SEC↗ |
| OCGN Ocugen, Inc. | A Award deriv | 2022-01-03 | 2022-01-05 | 454,007 | — | $0 | 454,007 | SEC↗ |
| OCGN Ocugen, Inc. | A Award | 2022-01-03 | 2022-01-05 | 125,534 | — | $0 | 161,125 | SEC↗ |
| OCGN Ocugen, Inc. | A Award deriv | 2021-12-16 | 2021-12-17 | 35,560 | — | $0 | 71,120 | SEC↗ |
| OCGN Ocugen, Inc. | A Award deriv | 2021-11-16 | 2021-11-18 | 35,560 | — | $0 | 35,560 | SEC↗ |
| OCGN Ocugen, Inc. | S Sale | 2021-10-26 | 2021-10-27 | 10,000 | $11.07 | $110.7K | 35,591 | SEC↗ |
| OCGN Ocugen, Inc. | M Exercise deriv | 2021-10-15 | 2021-10-15 | 7,990 | — | $0 | 7,990 | SEC↗ |
| OCGN Ocugen, Inc. | S Sale | 2021-10-15 | 2021-10-15 | 7,990 | $9.96 | $79.6K | 45,591 | SEC↗ |
| OCGN Ocugen, Inc. | M Exercise | 2021-10-15 | 2021-10-15 | 7,990 | $2.19 | $17.5K | 53,581 | SEC↗ |
| OCGN Ocugen, Inc. | M Exercise deriv | 2021-08-16 | 2021-08-18 | 30,000 | — | $0 | 246,170 | SEC↗ |
| OCGN Ocugen, Inc. | S Sale | 2021-08-16 | 2021-08-18 | 30,000 | $7.22 | $216.6K | 45,591 | SEC↗ |
| OCGN Ocugen, Inc. | M Exercise | 2021-08-16 | 2021-08-18 | 30,000 | $0.34 | $10.2K | 75,591 | SEC↗ |
| OCGN Ocugen, Inc. | M Exercise deriv | 2021-07-15 | 2021-07-16 | 31,086 | — | $0 | 276,170 | SEC↗ |
| OCGN Ocugen, Inc. | S Sale | 2021-07-15 | 2021-07-16 | 31,086 | $6.70 | $208.3K | 45,591 | SEC↗ |
| OCGN Ocugen, Inc. | M Exercise | 2021-07-15 | 2021-07-16 | 31,086 | $0.34 | $10.6K | 76,677 | SEC↗ |
| OCGN Ocugen, Inc. | M Exercise deriv | 2021-06-15 | 2021-06-17 | 31,000 | — | $0 | 307,256 | SEC↗ |
| OCGN Ocugen, Inc. | S Sale | 2021-06-15 | 2021-06-17 | 31,000 | $7.00 | $217.0K | 45,591 | SEC↗ |
| OCGN Ocugen, Inc. | M Exercise | 2021-06-15 | 2021-06-17 | 31,000 | $0.34 | $10.5K | 76,591 | SEC↗ |
| OCGN Ocugen, Inc. | M Exercise deriv | 2021-05-14 | 2021-05-14 | 31,000 | — | $0 | 338,256 | SEC↗ |
| OCGN Ocugen, Inc. | M Exercise | 2021-05-14 | 2021-05-14 | 31,000 | $0.34 | $10.5K | 76,591 | SEC↗ |
| OCGN Ocugen, Inc. | S Sale | 2021-05-14 | 2021-05-14 | 31,000 | $8.18 | $253.6K | 45,591 | SEC↗ |
| OCGN Ocugen, Inc. | M Exercise deriv | 2021-04-29 | 2021-05-03 | 7,990 | — | $0 | 15,980 | SEC↗ |
| OCGN Ocugen, Inc. | M Exercise | 2021-04-29 | 2021-05-03 | 7,990 | $2.19 | $17.5K | 53,581 | SEC↗ |
| OCGN Ocugen, Inc. | S Sale | 2021-04-29 | 2021-05-03 | 7,990 | $10.98 | $87.7K | 45,591 | SEC↗ |
| OCGN Ocugen, Inc. | M Exercise deriv | 2021-01-29 | 2021-02-01 | 35,591 | — | $0 | 71,183 | SEC↗ |
| OCGN Ocugen, Inc. | M Exercise | 2021-01-29 | 2021-02-01 | 35,591 | $0.51 | $18.2K | 45,591 | SEC↗ |
| OCGN Ocugen, Inc. | A Award deriv | 2021-01-01 | 2021-01-04 | 800,000 | — | $0 | 800,000 | SEC↗ |
| OCGN Ocugen, Inc. | A Award deriv | 2020-05-05 | 2020-05-07 | 369,256 | — | $0 | 369,256 | SEC↗ |
| OCGN Ocugen, Inc. | A Award deriv | 2020-01-02 | 2020-01-03 | 106,774 | — | $0 | 106,774 | SEC↗ |
| OCGN Ocugen, Inc. | P Buy | 2019-11-22 | 2019-11-26 | 5,000 | $0.28 | $1.4K | 10,000 | SEC↗ |
| OCGN Ocugen, Inc. | P Buy | 2019-10-02 | 2019-10-04 | 5,000 | $1.88 | $9.4K | 5,000 | SEC↗ |
| OCGN Ocugen, Inc. | A Award deriv | 2019-10-01 | 2019-10-04 | 23,970 | — | $0 | 23,970 | SEC↗ |